Glimpse Group raises ATM facility capacity to $9.48M; no shares sold to date

Glimpse Group, Inc.

Second amendment to ATM sales agreement with WestPark Capital dated January 2, 2026.
Maximum offering amount increased from $3,502,910 to $9,478,200.
No shares have been sold under the ATM facility as of the filing date.
Prior amendment on November 21, 2025 had raised the limit from $3.08M to $3.50M.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-000835
form_type: 8-K
ticker: GGRP
cik: 0001854445
company_name: Glimpse Group, Inc.
filed_at: 2026-01-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.554787+00:00
generated_at: 2026-05-16T11:24:55.352802+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-000835
json_url: https://secwatch.observer/filing/0001493152-26-000835.json
markdown_url: https://secwatch.observer/filing/0001493152-26-000835.md
text_url: https://secwatch.observer/filing/0001493152-26-000835.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1854445/000149315226000835/0001493152-26-000835-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1854445/000149315226000835/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

EMYB

Embassy Bancorp expands stock repurchase program by additional $5M

Embassy Bancorp, Inc. June 1, 2026, 4:37 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTXR

Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned

Citius Pharmaceuticals, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

MXL

MaxLinear dismisses Grant Thornton, appoints KPMG as auditor for FY2026

MAXLINEAR, INC June 1, 2026, 4:35 PM ET other_material Items 4.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

LXU

LSB Industries accelerates Pryor, OK turnaround start to May 28, 2026

LSB INDUSTRIES, INC. June 1, 2026, 4:35 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

SMC

Summit Midstream Corporation announces inaugural $35 million stock repurchase program

Summit Midstream Corp June 1, 2026, 4:31 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-000835

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.